GlassScriptPhysician profile
Ronald William Glinski
NPI 1801836747
$8,268.97
in general payments reported to CMS, 2019-2025
40 companies · $2,301 in 2025
The $2,301 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $578 · 2021: $597 · 2022: $321 · 2023: $1,321 · 2024: $1,753 · 2025: $2,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,936 · Travel and Lodging: $2,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,936.01 |
| Travel and Lodging | $2,439.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,941.92 | 2019-2025 | |
| Procept Biorobotics Corporation | $1,246.96 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $1,207.89 | 2019-2023 | Solyx Sis System |
| Medtronic, INC. | $913.98 | 2021-2025 | Interstim |
| Coloplast Corp | $518.22 | 2020-2025 | Porges Coloplast |
| Neotract INC. | $381.39 | 2019-2020 | |
| Astellas Pharma US INC | $215.53 | 2019-2024 | Xtandi |
| Abbvie INC. | $204.08 | 2021-2025 | |
| Axonics, INC. | $177.98 | 2022-2024 | Axonics |
| Teleflex LLC | $166.09 | 2021-2023 | Urolift |
| Allergan, INC. | $125.93 | 2019-2022 | |
| Janssen Biotech, INC. | $111.41 | 2019-2025 | |
| Medtronic USA, INC. | $106.05 | 2020 | |
| Urovant Sciences INC | $102.51 | 2022 | |
| Ferring Pharmaceuticals INC. | $93.80 | 2024-2025 | Adstiladrin |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Glinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.